A look at AstraZeneca's top performing drugs. Crestor, Symbicort, and Nexium are the best performing drugs by a large margin, however, with many
Want to stay on top of the science and politics driving biotech today? AstraZeneca drug that is considered standard of care. Biohaven
Figure 1 displays the sales values of the top ten products of AstraZeneca for 2024. Crestor, Symbicort, and Nexium are the best performing drugs
One of AstraZeneca Plc's top-selling drugs Farxiga, a diabetes treatment, is beneficial to a wider pool of patients than previously
AstraZeneca's Crestor stands at the top of the cardiovascular drugs heap for 2024, but 2024 will be a different story. Generic versions of the
Trial data shows blockbuster drug slows disease progression Tagrisso is already AstraZeneca's top-selling cancer drug.
AstraZeneca has spent $12 billion in research money for every new drug approved, as much as the top-selling medicine ever generated in annual
Total savings of top generic drugs in U.S. 2024; AstraZeneca's revenue from top product Nexium ; AstraZeneca's revenue from Nexium by region ; Leading antacid tablet brands in
biggest buyer of prescription drugsto negotiate how much it pays for high-price drugs. That could hurt AstraZeneca's top line by about $500
Comments